Found 0 matching trials
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PHASE2PRE-EMPT will assemble a cohort of 150 participants from three populations ...
Location
Multiple Locations
RCT of Psilocybin-assisted CBT for Depression
PHASE1The primary objectives of this clinical investigation are to (1) determine ...
Location
UCLA Semel Institute
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
PHASE2This clinical research study is to learn about the feasibility, safety, and...
Location
The University of Texas M. D. Anderson Cancer Center
Psilocybin-assisted CBT for Depression
PHASE1The primary objectives of this clinical investigation are to (1) determine ...
Location
UCLA Semel Institute
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
PHASE2This study aims to determine the safety and preliminary efficacy of psilocy...
Location
Brigham and Women's Hospital
Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
PHASE2This study is to find out about whether two sessions of psilocybin-assisted...
Location
Mount Sinai Comprehensive Cancer Center
Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study
PHASE2The PASSENGER project aims to conduct a pilot feasibility study of the impl...
Location
Nantes University Hospital
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
PHASE2The goal of this clinical trial is to learn whether it is possible to use p...
Location
UCSF at Zuckerberg San Francisco General Hospital
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
PHASE2The purpose of this study is to determine the safety and feasibility of per...
Location
Ghent University Hospital
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
N/AThis study aims to investigate whether oxytocin reactivity during a psyched...
Status
Enrolling By Invitation
Location
Geneva University Hospitals